Phenotypic screens with model organisms

Chemical Genomics

Volumn , Issue , 2012, Pages 121-136

  Wheeler, Grant N ^a   Field, Robert A ^b   Tomlinson, Matthew L ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923486117     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139021500.014     Document Type: Chapter

References (98)

1. Walsh, D. P., and Chang, Y. T. (2006). Chemical genetics. Chem Rev 106, 2476-2530.
2. Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850.
3. Van Raay, T. J., and Vetter, M. L. (2004). Wnt/frizzled signaling during vertebrate retinal development. Dev Neurosci 26, 352-358.
4. Davidson, E. H., Rast, J. P., Oliveri, P., Ransick, A., Calestani, C., Yuh, C. H., Minokawa, T., Amore, G., Hinman, V., Arenas-Mena, C., Otim, O., Brown, C. T., Livi, C. B., Lee, P. Y., Revilla, R., Rust, A. G., Pan, Z., Schilstra, M. J., Clarke, P. J., Arnone, M. I., Rowen, L., Cameron, R. A., McClay, D. R., Hood, L., and Bolouri, H. (2002). A genomic regulatory network for development. Science 295, 1669-1678.
5. Wheeler, G. N., and Brandlii, A. (2009) Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus. Dev Dyn 238, 1287-1308.
6. Blackwell, H. E., and Zhao, Y. (2003). Chemical genetic approaches to plant biology. Plant Physiol 133, 448-455.
7. Kaschani, F., and Van Der Hoorn, R. (2007). Small molecule approaches in plants. Curr Opin Chem Biol 11, 88-98.
8. Walsh, T. A. (2007).The emergingfield of chemical genetics: potential applications for pesticide discovery. Pest Manag Sci 63, 1165-1171.
9. Armstrong, J. L. (2007). Chemical genetics: catalysing pathway exploration and new target discovery. J Sci Food Agric 8 7, 1985-1990.
10. Wolfson, W. (2006). Spray-on special effects. Mendel Biotechnology uses chemical genetics to help plants cope with stress. Chem Biol 13, 919-921.
11. Arabidopsis, G. I. (2000). Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408, 796-815.
12. The Arabidopsis Information Resource. http://www. arabidopsis.org.
13. Lu, Y., Savage, L. J., Ajjawi, I., Imre, K. M., Yoder, D. W., Benning, C., Dellapenna, D., Ohlrogge, J. B., Osteryoung, K. W., Weber, A. P., Wilkerson, C. G., and Last, R. L. (2008). New connections across pathways and cellular pro-cesses: industrialized mutant screening reveals novel associa-tions between diverse phenotypes in Arabidopsis. Plant Physiol 146, 1482-1500.
14. Zouhar, J., Hicks, G. R., and Raikhel, N. V. (2004). Sorting inhibitors (sortins): chemical compounds to study vacuolar sorting in Arabidopsis. Proc Natl Acad Sci U S A 101, 9497-9501.
15. Surpin, M., Rojas-Pierce, M., Carter, C., Hicks, G. R., Vasquez, J., and Raikhel, N. V. (2005). The power of chemical genomics to study the link between endomembrane system components and the gravitropic response. Proc Natl Acad Sci USA 102, 4902-4907.
16. Carter, C. J., Bednarek, S. Y., and Raikhel, N. V. (2004). Membrane trafficking in plants: new discoveries and approaches. Curr Opin Plant Biol 7, 701-707.
17. Surpin, M., and Raikhel, N. (2004). Traffic jams affect plant development and signal transduction. Nat Rev Mol Cell Biol 5, 100-109.
18. Scheible, W. R., Eshed, R., Richmond, T., Delmer, D., and Somerville, C. (2001). Modifications of cellulose synthase confer resistance to isoxaben and thiazolidinone herbicides in Arabidopsis Ixr1 mutants. Proc Natl Acad Sci USA 98, 10079-10084.
19. Yoneda, A., Higaki, T., Kutsuna, N., Kondo, Y., Osada, H., Hasezawa, S., and Matsui, M. (2007). Chemical genetic screening identifies a novel inhibitor of parallel alignment of cortical microtubules and cellulose microfibrils. Plant Cell Physiol 48, 1393-1403.
20. DeBolt, S., Gutierrez, R., Ehrhardt, D. W., Melo, C. V., Ross, L., Cutler, S. R., Somerville, C., and Bonetta, D. (2007). Mor-lin, an inhibitor of cortical microtubule dynamics and cellulose synthase movement. Proc Natl Acad Sci USA 104, 5854-5859.
21. Zhao, Y., Dai, X., Blackwell, H. E., Schreiber, S. L., and Chory, J. (2003). SIR1, an upstream component in auxin signaling identified by chemical genetics. Science 301, 1107-1110.
22. Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., and Schreiber, S. L. (2001). Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. JBiol Chem 276, 38837-38843.
23. Dai, X., Hayashi, K., Nozaki, H., Cheng, Y., and Zhao, Y. (2005). Genetic and chemical analyses of the action mechanisms of sirtinol in Arabidopsis. Proc Natl Acad Sci USA 102, 3129-3134.
24. Asami, T., Nakano, T., Nakashita, H., Sekimata, K., Shimada, Y., and Yoshida, S. (2003). The influence of chemical genetics on plant science: shedding light on functions and mechanism of action of brassinosteroids using biosynthesis inhibitors. J Plant Growth Regul 22, 336-349.
25. Kaletta, T., and Hengartner, M. O. (2006). Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 5, 387-398.
26. Li, C., and Chalfie, M. (1990). Organogenesis in C. Elegans: positioning of neurons and muscles in the egg-laying system. Neuron 4, 681-695.
27. Carroll, P. M., Dougherty, B., Ross-Macdonald, P., Brow-man, K., and FitzGerald, K. (2003). Model systems in drug discovery: chemical genetics meets genomics. Pharmacol Ther 99, 183-220.
28. Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., Welchman, D. P., Zipperlen, P., and Ahringer, J. (2003). Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237.
29. Pulak, R. (2006). Techniques for analysis, sorting, and dis-pensing of C. elegans on the COPAS flow-sorting system. Methods Mol Biol 351, 275-286.
30. Boyd, W. A., McBride, S. J., and Freedman, J. H. (2007). Effects of genetic mutations and chemical exposures on Caenorhabditis elegans feeding: evaluation of a novel, high-throughput screening assay. PLoS ONE 2, e1259.
31. Schafer, W. R. (2005). Deciphering the neural and molecular mechanisms of C. elegans behavior. CurrBiol 15, R723-R729.
32. Taguchi, A., and White, M. F. (2008). Insulin-like signaling, nutrient homeostasis, and life span. Annu Rev Physiol 70, 191-212.
33. Min, J., Kyung Kim, Y., Cipriani, P. G., Kang, M., Kherson-sky, S. M., Walsh, D. P., Lee, J. Y., Niessen, S., Yates, J. R., III, Gunsalus, K., Piano, F., and Chang, Y. T. (2007). Forward chemical genetic approach identifies new role for GAPDH in insulin signaling. Nat Chem Biol 3, 55-59.
34. Kwok, T. C., Ricker, N., Fraser, R., Chan, A. W., Burns, A., Stanley, E. F., McCourt, P., Cutler, S. R., and Roy, P. J. (2006). A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441, 91-95.
35. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., and Ausubel, F. M. (2006). Identification of novel antimicro-bials using a live-animal infection model. Proc Natl Acad Sci U SA 103, 10414-10419.
36. Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F.M., and Mylonakis, E. (2007). Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3, e18.
37. Jones, A. K., Buckingham, S. D., and Sattelle, D. B. (2005). Chemistry-to-gene screens in Caenorhabditis elegans. Nat Rev Drug Discov 4, 321-330.
38. Segalat, L. (2006). Drug discovery: here comes the worm. ACS Chem Biol 1,277-278.
39. Bhavsar, A. P., and Brown, E. D. (2006). The worm turns for antimicrobial discovery. Nat Biotechnol 24, 1098-1100.
40. Chakrapani, B. P., Kumar, S., and Subramaniam, J. R. (2008). Development and evaluation of an in vivo assay in Caenorhab-ditis elegans for screening of compounds for their effect on cytochrome P450 expression. JBiosci 33, 269-277.
41. Van Den Heuvel, S. (2005). The C. elegans cell cycle: overview of molecules and mechanisms. Methods Mol Biol 296, 51-67.
42. Chan, H. Y. (2002). Flying from genes to drugs. Trends Mol Med 8, 99-101.
43. Segalat, L. (2007). Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol 2,231-236.
44. Garcia-Lopez, A., Monferrer, L., Garcia-Alcover, I., Vicente-Crespo, M., Alvarez-Abril, M. C., and Artero, R. D. (2008). Genetic and chemical modifiers of a CUG toxicity model in Drosophila. PLoS ONE 3, e1595.
45. Chang, S., Bray, S. M., Li, Z., Zarnescu, D. C., He, C., Jin, P., and Warren, S. T. (2008). Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4, 256-263.
46. ffrench-Constant, R. H., Steichen, J. C., Rocheleau, T. A., Aronstein, K., and Roush, R. T. (1993). A single-amino acid substitution in a gamma-aminobutyric acid subtype A receptor locus is associated with cyclodiene insecticide resistance in Drosophila populations. Proc Natl Acad Sci USA90, 1957-1961.
47. Kang, H. L., Benzer, S., andMin, K.T. (2002). Life extension in Drosophila by feeding a drug. Proc Natl Acad Sci U S A 99, 838-843.
48. Chen, E., and Ekker, S. C. (2004). Zebrafish as a genomics research model. Curr Pharm Biotechnol 5, 409-413.
49. Berger, J., and Currie, P. (2007). The role of zebrafish in chemical genetics. Curr Med Chem 14, 2413-2420.
50. MacRae, C. A., and Peterson, R. T. (2003). Zebrafish-based small molecule discovery. Chem Biol 10, 901-908.
51. Sprague, J., Clements, D., Conlin, T., Edwards, P., Frazer, K., Schaper, K., Segerdell, E., Song, P., Sprunger, B., and Westerfield, M. (2003). The Zebrafish Information Network (ZFIN): the zebrafish model organism database. Nucleic Acids Res31, 241-243.
52. Zon, L. I., and Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4, 35-44.
53. Goessling, W., North, T. E., and Zon, L. I. (2007). New waves of discovery: modeling cancer in zebrafish. J Clin Oncol 25, 2473-2479.
54. Langenau, D. M., Traver, D., Ferrando, A. A., Kutok, J. L., Aster, J. C., Kanki, J. P., Lin, S., Prochownik, E., Trede, N.S., Zon, L. I., and Look, A. T. (2003). Myc-induced T cell leukemia in transgenic zebrafish. Science 299, 887-890.
55. Langenau, D. M., and Zon, L. I. (2005). The zebrafish: anew model of T-cell and thymic development. Nat Rev Immunol 5, 307-317.
56. Stoletov, K., and Klemke, R. (2008). Catch of the day: zebrafish as a human cancer model. Oncogene 27, 45094520.
57. Patton, E. E., and Zon, L. I. (2005). Taking human cancer genes to the fish: a transgenic model of melanoma in zebrafish. Zebrafish 1, 363-368.
58. White, R. M., Sessa, A., Burke, C., Bowman, T., LeBlanc, J., Ceol, C., Bourque, C., Dovey, M., Goessling, W., Burns, C. E., and Zon, L. I. (2008). Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2, 183-189.
59. Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L., and Klemke, R. (2007). High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. ProcNatl AcadSci USA 104, 17406-17411.
60. Haldi, M., Ton, C., Seng, W. L., and McGrath, P. (2006). Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9, 139-151.
61. Ceol, C. J., Houvras, Y., Jane-Valbuena, J., Bilodeau, S., Orlando, D. A., Battisti, V., Fritsch, L., Lin, W. M., Holl-mann, T. J., Ferre, F. et al. (2011). The histone methyltrans-ferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471, 513-517.
62. White, R. M., Cech, J., Ratanasirintrawoot, S., Lin, C. Y., Rahl, P. B., Burke, C. J., Langdon, E., Tomlinson, M. L., Mosher, J., Kaufman, C., Chen, F., Long, H. K., Kramer, M., Datta, S., Neuberg, D., Granter, S., Young, R. A., Morrison, S., Wheeler, G. N., Zon, L. I. (2011) DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518-522.
63. Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A., and Fishman, M. C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 22, 595-599.
64. Owens, K. N., Santos, F., Roberts, B., Linbo, T., Coffin, A. B., Knisely, A. J., Simon, J. A., Rubel, E. W., and Raible, D. W. (2008). Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet 4, e1000020.
65. Murphey, R. D., Stern, H. M., Straub, C. T., and Zon, L. I. (2006). A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 68, 213-219.
66. Hill, A. J., Teraoka, H., Heideman, W., and Peterson, R. E. (2005). Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86, 6-19.
67. Barros, T. P., Alderton, W. K., Reynolds, H.M., Roach, A. G., and Berghmans, S. (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 154, 1400-1413.
68. Spitsbergen, J. M., and Kent, M. L. (2003). The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol Pathol 31 Suppl, 62-87.
69. Redfern, W. S., Waldron, G., Winter, M. J., Butler, P., Hol-brook, M., Wallis, R., and Valentin, J. P. (2008). Zebrafish assays as early safety Pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods.
70. Richards, S. M., and Cole, S. E. (2006). A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 15, 647-656.
71. Berghmans, S., Butler, P., Goldsmith, P., Waldron, G., Gard-ner, I., Golder, Z., Richards, F. M., Kimber, G., Roach, A., Alderton, W., and Fleming, A. (2008). Zebrafish based assays for the assessment of cardiac, visual and gut function-potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 58, 59-68.
72. Winter, M. J., Redfern, W. S., Hayfield, A. J., Owen, S. F., Valentin, J. P., and Hutchinson, T. H. (2008). Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods 57, 176-187.
73. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T., and MacRae, C. A. (2003). Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358.
74. Burns, C. G., Milan, D. J., Grande, E. J., Rottbauer, W., MacRae, C. A., and Fishman, M. C. (2005). High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 1, 263-264.
75. Carney, S. A., Prasch, A. L., Heideman, W., and Peterson, R. E. (2006). Understanding dioxin developmental toxicity using the zebrafish model. Birth Defects Res A Clin Mol Teratol 76, 7-18.
76. Peterson, R. T., Link, B. A., Dowling, J. E., and Schreiber, S. L. (2000). Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 97, 12965-12969.
77. Mathew, L. K., Sengupta, S., Kawakami, A., Andreasen, E. A., Lohr, C. V., Loynes, C. A., Renshaw, S. A., Peterson, R. T., and Tanguay, R. L. (2007). Unraveling tissue regeneration pathways using chemical genetics. J Biol Chem 282, 35202-35210.
78. Jung, D. W., Williams, D., Khersonsky, S. M., Kang, T. W., Heidary, N., Chang, Y. T., and Orlow, S. J. (2005). Iden-tification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst 1, 85-92.
79. Khersonsky, S. M., Jung, D. W., Kang, T. W., Walsh, D. P., Moon, H. S., Jo, H., Jacobson, E. M., Shetty, V., Neubert, T.A., and Chang, Y. T. (2003). Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc 125, 11804-11805.
80. Sachidanandan, C., Yeh, J. R., Peterson, Q. P., and Peterson, R. T. (2008). Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS ONE 3, e1947.
81. Chan, J., Bayliss, P. E., Wood, J. M., and Roberts, T. M. (2002). Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1, 257-267.
82. Molina, G. A., Watkins, S. C., and Tsang, M. (2007). Generation of FGF reporter transgenic zebrafish and their utility in chemical screens. BMC Dev Biol 7, 62.
83. Longo, M., Zanoncelli, S., Della Torre, P., Rosa, F., Giusti, A., Colombo, P., Brughera, M., Mazue, G., and Olliaro, P. (2008). Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Terato-genesis Assay-Xenopus (FETAX). Reprod Toxicol 25,433-441.
84. Goda, T., Abu-Daya, A., Carruthers, S., Clark, MD., Stemple, DL., Zimmerman, LB., (2006). Genetic screens for mutations affecting development of Xenopus tropicalis. PLoS Genet. Jun;2(6):e91.
85. Brandli, A. (2004). Prospects for the XenopusEmbryo model in therapeutics technologies. Chimia 58, 694-702.
86. Tomlinson, M., Field, R. A., and Wheeler, G. N. (2005). Xenopus as a model organism in developmental chemical genetic screens. Molecular BioSystems 1, 223-228.
87. Adams, D. S., and Levin, M. (2006). Inverse drug screens: a rapid and inexpensive method for implicating molecular targets. Genesis 44, 530-540.
88. Fini, J. B., Le Mevel, S., Turque, N., Palmier, K., Zalko, D., Cravedi, J. P., and Demeneix, B. A. (2007). An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ Sci Technol 41, 5908-5914.
89. Matthew L. Tomlinson, Martin Rejzek, MarkFidock, Robert A. Field and Grant N. Wheeler. (2009). Chemical genomics identifies compounds affecting Xenopus laevis pigment cell development. Molecular BioSystems, 5, 376-384.
90. Tomlinson, M. L., Guan, P., Morris, R. J., Fidock, M. D., Rejzek, M., Garcia-Morales, C., Field, R. A., and Wheeler, G. N. (2009). A chemical genomic approach identifies matrix metalloproteinases as playing an essential and specific role in Xenopus melanophore migration. ChemBiol 16, 93-104.
91. Dale, L., and Slack, J. M. (1987). Fate map for the 32-cell stage ofXenopus laevis. Development 99, 527-551.
92. Dupre, A., Boyer-Chatenet, L., Sattler, R. M., Modi, A. P., Lee, J. H., Nicolette, M. L., Kopelovich, L., Jasin, M., Baer, R., Paull, T. T., and Gautier, J. (2008). A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 4, 119-125.
93. Peterson, J. R., Lebensohn, A. M., Pelish, H. E., and Kirschner, M. W. (2006). Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components. Chem Biol 13, 443-452.
94. Nusslein-Volhard, C., and Wieschaus, E. (1980). Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801.
95. Page-McCaw, A., Ewald, A. J., and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221-233.
96. Adams, D. S., Robinson, K. R., Fukumoto, T., Yuan, S., Albertson, R. C., Yelick, P., Kuo, L., McSweeney, M., and Levin, M. (2006). Early, H +-V-ATPase-dependent proton flux is necessary for consistent left-right patterning of non-mammalian vertebrates. Development 133, 1657-1671.
97. Fukumoto, T., Kema, i. P., and Levin, M. (2005). Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. CurrBiol 15, 794-803.
98. Levin, M., Buznikov, G. A., and Lauder, J. M. (2006). Of minds and embryos: left-right asymmetry and the serotonergic controls of pre-neural morphogenesis. Dev Neurosci 28, 171-185.